Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Immuron Limited ( (AU:IMC) ) just unveiled an update.
Immuron Limited has issued 135,800 ordinary shares without disclosure under Part 6D.2 of the Corporations Act. The company has complied with the relevant provisions of the Corporations Act and confirms there is no excluded information required to be disclosed, indicating a transparent and compliant operational stance.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry and is primarily focused on the development and commercialization of oral immunotherapeutic products for the treatment of gut-mediated diseases.
Average Trading Volume: 108,473
Technical Sentiment Signal: Sell
Current Market Cap: A$14.72M
Learn more about IMC stock on TipRanks’ Stock Analysis page.